@article {Limmol.109.063040, author = {Herman D Lim and Chris de Graaf and Wen Jiang and Payman Sadek and Patricia M McGovern and Enade P Istyastono and Remko A Bakker and Iwan J.P. de Esch and Robin L. Thurmond and Rob Leurs}, title = {Molecular determinants of ligand binding to H4R species variants}, elocation-id = {mol.109.063040}, year = {2010}, doi = {10.1124/mol.109.063040}, publisher = {American Society for Pharmacology and Experimental Therapeutics}, abstract = {The histamine H4 receptor (H4R) is the latest identified histamine receptor that is emerging as a potential drug target for inflammatory diseases. Animal models are employed to validate this potential drug target. Concomitantly, various H4R orthologs have been cloned, including the human, mouse, rat, guinea pig, monkey, pig, and dog H4Rs. In this paper, we expressed all these H4R orthologs in HEK 293T cells and compared their interactions with currently used standard H4R ligands, including the H4R agonists histamine, 4-methylhistamine, VUF 8430, the H4R antagonists JNJ 7777120 and VUF 6002, and the inverse H4R agonist thioperamide. Most of the evaluated ligands display significantly different affinities at the different H4R orthologs. These "natural mutants" of H4R were used to study ligand-receptor interactions using chimeric human-pig-human and pig-human-pig H4R proteins and site-directed mutagenesis. Our results are a useful reference for ligand selection for studies in animal models of diseases and offer new insights in the understanding of H4R-ligand receptor interactions.The American Society for Pharmacology and Experimental Therapeutics}, issn = {0026-895X}, URL = {https://molpharm.aspetjournals.org/content/early/2010/01/26/mol.109.063040}, eprint = {https://molpharm.aspetjournals.org/content/early/2010/01/26/mol.109.063040.full.pdf}, journal = {Molecular Pharmacology} }